Abstract:Objective: To explore the cohort study of rivaroxaban combined with D-dimer dynamic monitoring in the prevention of deep venous thrombosis (DVT) after knee arthroplasty. Methods: Eighty-four patients with knee osteoarthritis who went through total knee arthroplasty from June 2019 to June 2021 in our hospital were arbitrarily assigned into the study group and the control group. The patients in the control group were cured with rivaroxaban anticoagulation after operation, and the study group was cured with dynamic monitoring of D-dimer on the basis of the control group. The incidence of postoperative DVT, pulmonary embolism (PE), and bleeding complications (incision ecchymosis and bleeding events) were compared. The related indexes such as drainage volume and blood transfusion volume were compared. The levels of activated partial prothrombin time (APPT), prothrombin time (PT), and D-dimer were dynamically monitored before and after operation. Visual analogue scale (VAS) was adopted to assess the degree of postoperative incision pain, the level of limb swelling before and after operation was measured, the circumference difference of affected limb was calculated, the ecchymosis area was assessed in the form of nine-palace grid, and the scores were compared. Results: According to the comparison of VAS score, there exhibited no remarkable difference before operation and on the first day after operation, but the VAS score decreased after operation, and the VAS score of the study group on the 3rd day, 7th day, and 14th day after operation was remarkably lower compared to the control group (P < 0.05). There exhibited no remarkable difference in drainage volume (P > 0.05), but the blood transfusion volume and total blood loss in the study group were remarkably lower (P < 0.05). There exhibited no remarkable difference in the level of PT on the 3rd day before operation and on the 3rd day after operation, but on the 7th day and 14th day after operation, the level of PT in the study group was remarkably higher (P < 0.05). The level of PT in the study group was remarkably higher (P < 0.05). There exhibited no remarkable difference in the level of APPT on the 3rd day before operation and on the 3rd day after operation, but on the 7th day and 14th day after operation, the level of APPT in the study group was remarkably higher (P < 0.05). The level of APPT in the study group was remarkably higher (P < 0.05). There exhibited no remarkable difference in the level of plasma D-dimer before operation (P > 0.05). The level of plasma D-dimer in the study group was lower (P < 0.05). In terms of the postoperative ecchymosis area score, the ecchymosis area score decreased remarkably after operation. Furthermore, the ecchymosis area score of the study group was remarkably lower (P < 0.05). In terms of the swelling degree of the affected limb, there exhibited no remarkable difference in thigh circumference and calf circumference before operation (P > 0.05), but after operation, the thigh circumference difference and calf circumference difference decreased, and the thigh circumference difference and calf circumference difference in the study group were lower (P < 0.05). The incidence of DVT in the study group was 16.67%, while that in the control group was 38.10%. No PE occurred in the two groups at the early stage after operation. There were 3 cases of incision ecchymosis, 1 case of bleeding event (incision oozing) in the study group, 11 cases of incisional ecchymosis, and 2 cases of bleeding event in the control group. In 3 patients with incisional bleeding, there were no obvious abnormalities in routine blood examination and blood coagulation indexes. The patients were given wound pressure bandaging and stopped using anticoagulants and changing wound dressings every day, all of which disappeared within 5 days. The incidence of early postoperative DVT and bleeding complications in the study group was lower (P < 0.05). Conclusion: Rivaroxaban combined with D-dimer dynamic monitoring has high clinical value in preventing DVT after knee arthroplasty and can effectively reduce the amount of blood loss during operation and the incidence of postoperative DVT, PE, and bleeding complications, which is worth popularizing to reduce the area of ecchymosis and the degree of pain after operation and shorten the recovery process.

A Cohort Study of Rivaroxaban Combined with D-Dimer Dynamic Monitoring in the Prevention of Deep Venous Thrombosis after Knee Arthroplasty

Direct Factor Xa Inhibitors (rivaroxaban and Apixaban) Versus Enoxaparin for the Prevention of Venous Thromboembolism after Total Knee Replacement: A Meta-Analysis of 6 Randomized Clinical Trials

SAFETY AND EFFICACY OF RIVAROXABAN FOR PREVENTION OF DEEP VEIN THROMBOSIS IN PATIENTS WITH PREOPERATIVE ABNORMAL D-DIMER AFTER TOTAL KNEE ARTHROPLASTY

Administering Aspirin, Rivaroxaban and Low-Molecular-weight Heparin to Prevent Deep Venous Thrombosis after Total Knee Arthroplasty

Low-molecular-weight heparin followed by rivaroxaban or not for the prevention of deep venous thromboembolism after total knee arthroplasty.

Prophylactic efficacy of two anticoagulant drug heparin calcium and rivaroxaban, on venous thrombosis after knee arthroplasty

Effect of Rivaroxaban verses Low Molecular Weight Heparin on Preventing Deep Vein Thrombosis in Postoperative Hip or Knee Arthroplasty

Clinical Study of Deep Venous Thrombosis Prevention after Total Hip Arthroplasty with Oral Rivaroxaban

Clinical effect of rivaroxaban and enoxaparin on the prevention of lower deep vein thrombosis after artificial knee joint replacement

Intermittent Pneumatic Compression Devices Combined with Anticoagulants for Prevention of Symptomatic Deep Vein Thrombosis after Total Knee Arthroplasty: a Pilot Study

Significance of dynamically monitoring D-dimer on prevention of acute deep vein thrombosis of lower limbs

Curative effect of rivaroxaban versus low molecular weight heparin to prevent deep venous thrombosis following total hip arthroplasty

Efficacy comparison of rivaroxaban and Low Molecular Weight heparin in preventing deep venous thrombosis after hip replacement

Early incidence of deep venous thrombosis and its risk factors after knee arthroscopic surgery in patients with anticoagulant and non-anticoagulant

Rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total knee arthroplasty: A meta-analysis.

Rivaroxaban Versus Enoxaparin for the Prevention of Venous Thromboembolism after Total Knee Arthroplasty

Early incidence of deep venous thrombosis and its early marker after knee arthroscopy: A retrospective study with routinely applied ultrasonography

Comparison of the efficacy of rivaroxaban and dabigatran etexilate in preventing venous thrombosis after arthroplasty: A protocol of randomized controlled trial

Efficacy and safety of rivaroxaban for thromboprophylaxis after orthopedic surgery: a Meta-analysis

Compare Prophylactic Effects of Rivaroxaban with Low Molecular Heparin on Deep Vein Thrombosis after Hip Replacement

Postoperative plasma D-dimer value for predicting deep venous thrombosis following hip arthroplasty with nadroparin prophylaxis.